BioInvent competitorsClear all

BioInvent's top competitors include Cellectar Biosciences, A&G Pharmaceutical, Isotopen Technologien Munchen and Calviri.
BioInvent
BioInvent
BioInvent focuses on the discovery and development of antibody-based drugs against cancer.
Cellectar Biosciences
Cellectar Biosciences
Cellectar Biosciences is a clinical stage biopharmaceutical company that engages in the development of targeted phospholipid drug conjugates for the treatment and imaging of cancer.
A&G Pharmaceutical
A&G Pharmaceutical
A&G Pharmaceutical is a company that discovers and develops theranostic products.
Isotopen Technologien Munchen
Isotopen Technologien Munchen
ITM Isotopen Technologien Munchen is a company that develops, produces, and supplies diagnostic and therapeutic radionuclides and radiopharmaceuticals for use in cancer treatment.
Calviri
Calviri
Calviri is a company that develops diagnostic and therapeutic products, as well as vaccines aimed to prevent cancer.
Founding Date
Founding Date
1997
Founding Date
1996
Founding Date
2000
Founding Date
2004
Founding Date
2018
Type
Type
Public
Type
Public
Type
Private
Type
Private
Type
Private
Tags
Locations
Locations
Lund, SE HQ
Lund, SE
Locations
Madison, US HQ
Florham Park, US
Locations
Columbia, US HQ
Locations
Garching bei München, DE HQ
München, DE
Locations
HQ
Employees
Employees
724% increase
Employees
753% decrease
Employees
2
Employees
554% increase
Employees
5
Valuation ($)
Valuation ($)
176.5 m
Valuation ($)
34 m
Valuation ($)
N/A
Valuation ($)
N/A
Valuation ($)
N/A
Twitter followers
Twitter followers
N/A
Twitter followers
484
Twitter followers
N/A
Twitter followers
785
Twitter followers
N/A
Number of tweets (last 30 days)
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
4
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
4
Number of tweets (last 30 days)
N/A
Average likes per tweet (last 30 days)
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
1.5
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
2
Average likes per tweet (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
75%
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
75%
Percentage of tweets with engagement (last 30 days)
N/A
Alexa Website Rank
Alexa Website Rank
311182
Alexa Website Rank
301103
Alexa Website Rank
270129
Alexa Website Rank
N/A
Alexa Website Rank
264013
Employee Rating
Employee Rating
N/A
Employee Rating
N/A
Employee Rating
3
Employee Rating
N/A
Employee Rating
N/A

Funding

Latest funding round
Latest funding round
N/A
Latest funding round
N/A
Latest funding round
$ 100k (over 10 years ago)
Latest funding round
$ 22m (over 4 years ago)
Latest funding round
$ 2.3m (7 months ago)
Total funding raised
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
$ 2.1m
Total funding raised
$ 22m
Total funding raised
$ 2.3m
For sources of this data, please see the company profile

View company profiles

Cellectar Biosciences
HQ
Madison, US
Employees
7

Cellectar Biosciences is a clinical stage biopharmaceutical company that engages in the development of targeted phospholipid drug conjugates for the treatment and imaging of cancer.

View company
A&G Pharmaceutical
HQ
Columbia, US
Employees
2

A&G Pharmaceutical is a company that discovers and develops theranostic products.

View company
Isotopen Technologien Munchen
HQ
Garching bei München, DE
Employees
55↑ 4% increase

ITM Isotopen Technologien Munchen is a company that develops, produces, and supplies diagnostic and therapeutic radionuclides and radiopharmaceuticals for use in cancer treatment.

View company
Calviri
HQ
Employees
5

Calviri is a company that develops diagnostic and therapeutic products, as well as vaccines aimed to prevent cancer.

View company